Exercise-Derived Vesicles: A Breakthrough in Cancer Therapy
Researchers led by Silvestri et al. have shown that extracellular vesicles released during physical exercise carry proteins, lipids and RNA that can influence tumor biology. The study demonstrates that these exercise‑derived EVs can boost immune recognition of cancer cells and serve as biomarkers for disease progression. By characterizing the vesicle cargo, the team proposes new nanomedicine approaches that could complement or replace traditional exercise in patients unable to train. Early results suggest a pathway toward personalized immunotherapy integrated with lifestyle interventions.
Key Factors in Cardiovascular Care Delivery
A new BMC Health Services Research study by Durmuş and Akbolat maps the expectations of cardiovascular patients across clinical, interpersonal, environmental, digital, and demographic dimensions. The research reveals that empathy, provider competence, and a welcoming care environment are as critical...
Advanced TadA Editors Enable Precise Disease Variant Modeling
Researchers have unveiled next‑generation TadA‑based adenine base editors that achieve near‑perfect A‑to‑G conversion at disease‑relevant loci. The editors demonstrate editing efficiencies up to 95% with off‑target rates below 0.1%, and have been used to generate more than 30 pathogenic point...
Teva CEO Says It Has Successfully Transitioned Into a Biopharma Company
Teva Pharmaceutical Industries announced that its latest earnings demonstrate a completed shift from a pure‑play generics manufacturer to a biopharma‑focused enterprise. The CEO highlighted that revenue from specialty and branded products now exceeds traditional generic sales, confirming the strategic pivot....
Dual-Channel High-Speed Photoacoustic Microscopy Revolutionizes Wide Imaging
Researchers unveiled a dual‑channel high‑speed photoacoustic microscopy system that captures wide‑field images up to 10 mm in a single shot, effectively doubling acquisition speed compared with single‑channel setups. The platform synchronizes two laser beams and parallel acoustic detectors, delivering sub‑micron resolution...
Glucose Monitoring with Novel Reusable Sensor
Hamilton has launched the GlucoSense reusable sensor, a compact inline probe that provides real‑time glucose monitoring for mammalian cell cultures. The device uses infrared spectrometry and integrates directly with its transmitter, eliminating the need for an external spectrometer or lengthy...
Permittivity Provides an In-Line Cell Health Early-Warning System
Merck scientists demonstrated that dielectric spectroscopy, measured as permittivity, can serve as an in‑line early‑warning system for apoptosis in CHO cell cultures. By analyzing Cole‑Cole model parameters—critical frequency (fc) and delta epsilon (Δε)—they captured stress‑induced shifts before conventional viability assays...
PH Denaturation of dsRNA for mRNA Purification
Scientists at Sartorius BIA Separations and Johannes Gutenberg University have introduced a low‑pH denaturation step that melts double‑stranded RNA (dsRNA) impurities in mRNA streams within seconds. By adjusting the pH to 3.5 or lower, dsRNA levels fall below 0.1% while...
Rethinking Vaccine Production Platforms for Future Pandemics
New analysis highlights yeast-based protein expression as a promising vaccine platform for future pandemics. While mRNA and viral vector technologies enabled rapid COVID‑19 vaccine rollout, their high cost, manufacturing complexity, and cold‑chain requirements limited access in low‑income regions. Yeast systems...
LINC00857 Drives Pancreatic Cancer via miR-130b/RHOA
Researchers have identified the long non‑coding RNA LINC00857 as a driver of pancreatic ductal adenocarcinoma through a miR‑130b/RHOA signaling axis. The study shows LINC00857 is overexpressed in patient tumors and functions as a molecular sponge, sequestering miR‑130b and thereby upregulating...
SiRNA Transport Drives Pollen Development Functions
Researchers have uncovered that small interfering RNA (siRNA) molecules are actively transported from the vegetative nucleus to sperm cells during pollen development, a process essential for proper gene silencing. The study, conducted in Arabidopsis thaliana, shows that disrupting siRNA transport...
Function of Cell Surface glycoRNAs Identified
Researchers led by Ryan Flynn have identified the cellular pathway that places glycoRNAs on the cell surface and demonstrated that these RNA‑glycan hybrids bind and inhibit VEGF‑A signaling. Genetic screens linked heparan sulfate to glycoRNA presentation, and loss of glycoRNAs...
Malabsorption Detected by Glowing Bacterial Biosensors in Mice
University of British Columbia researchers engineered the native gut bacterium Bacteroides thetaiotaomicron to act as a continuous, noninvasive biosensor that glows brightly under normal conditions and dims when osmotic stress indicates malabsorption. Published in Cell, the study demonstrated in mice...
AI Tool AlphaGenome Predicts How One Typo Can Change a Genetic Story
Google DeepMind unveiled AlphaGenome, a deep‑learning model that can process one million DNA bases in a single context, doubling the reach of its predecessor Borzoi. The system predicts eleven genomic functions at single‑base resolution, delivering a 14.7% improvement in gene‑activity...
REGENXBIO Delay Could Put Denali in Pole Position for Hunter Syndrome Approval
The FDA placed a clinical hold on REGENXBIO’s RGX‑111 and RGX‑121 after a tumor was found in a five‑year‑old patient potentially linked to the AAV vector. The hold jeopardizes REGENXBIO’s Feb. 8, 2026 PDUFA deadline for its Hunter syndrome gene therapy. Denali...
HHS Seeks to Protect Drugmakers From Anti-Kickback Laws Ahead of TrumpRx Launch
The U.S. Department of Health and Human Services announced a draft rule that would create a safe‑harbor exemption for drug manufacturers participating in the upcoming TrumpRx platform. The proposal seeks to shield companies from the federal anti‑kickback statute when they...
Hengrui Blazes Trail as Chinese Drugmakers Aspire to Go Multinational
Jiangsu Hengrui Pharmaceuticals has surged into the global top‑25 biopharma companies by market value, marking a dramatic shift from its previously low international profile. The Chinese firm leveraged a pipeline of innovative oncology and immunology drugs, securing multiple foreign regulatory...
Halozyme Buys Drug Delivery Biotech Surf Bio; Sanofi Backs Sensorion
Halozyme Therapeutics announced a $300 million upfront acquisition of drug‑delivery biotech Surf Bio, adding its PEGylated enzyme platform to Halozyme’s existing portfolio. The deal is expected to broaden Halozyme’s subcutaneous biologics pipeline and accelerate commercialization of next‑generation delivery technologies. Concurrently, Sanofi...
NK Cell Insights Into Ankylosing Spondylitis Severity
Recent immunological research reveals that natural killer (NK) cells play a pivotal role in the severity of ankylosing spondylitis (AS). The study found a proportional increase in peripheral NK cell frequency and activation markers correlating with higher Bath Ankylosing Spondylitis...
J&J’s Darzalex Faspro Notches Another Multiple Myeloma Indication, Pushing Into Frontline
The FDA approved Johnson & Johnson’s Darzalex Faspro as part of a four‑drug regimen for newly diagnosed multiple myeloma patients who cannot undergo stem cell transplantation. This is the drug’s twelfth overall and fifth frontline indication. Phase III CEPHEUS data showed 52.3%...
IXCells and Rosebud Biosciences Partner on Organoid-Based Rare Disease Models
iXCells Biotechnologies is integrating Rosebud Biosciences’ AI‑driven organoid platform with its iPSC‑based iPSCore system to deliver scalable, three‑dimensional human tissue models. The partnership combines iXCells’ modular stem‑cell production with Rosebud’s reproducible organoid generation and characterization capabilities. Together they aim to...
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
Advanced Therapies Week 2026 in San Diego will spotlight the accelerating yet turbulent landscape of cell and gene therapies. New FDA guidance, including the plausible‑mechanism pathway, promises faster approvals, while recent U.S. cuts to mRNA projects and a wave of...
CD81’s Role in Immune Response and Myeloma Prognosis
Recent studies identify CD81, a tetraspanin protein, as a key regulator of immune cell function in multiple myeloma. Patients exhibit reduced CD81 on T cells, impairing anti‑tumor responses, while higher overall CD81 levels correlate with improved survival and therapy response....
Cardiff Craters Amid Executive Exits, Mixed Mid-Stage Data
Cardiff Oncology announced the departure of its CEO and CFO while releasing mixed Phase II data for its PLK1 inhibitor onvansertib. In the CRDF‑004 trial, the 30 mg dose combined with FOLFIRI + bevacizumab achieved a 72.2% objective response rate and a 62% reduction...
Boehringer Drug Scores in Rare Kidney Disease FSGS
Boehringer Ingelheim’s TRPC6 inhibitor apecotrep, originally a COVID‑19 candidate, achieved a 40% reduction in proteinuria versus placebo in a phase 2 trial for primary focal segmental glomerulosclerosis (FSGS). The study, published in The Lancet, provides the first efficacy signal for a...
Biopharma Sentiment Index | Q1 2026
The Biopharma Sentiment Index (BPSI) jumped to 90 in Q1 2026, up from 78 in the prior quarter, marking the strongest sentiment shift in four years. All ten core measures improved, driven chiefly by a surge in dealmaking and better access...
Laser-Activated Nanodroplets Enable Photo-Activated Ultrasound Imaging
Researchers introduced photo‑activated ultrasound localization imaging (PAULI), using laser‑activated nanodroplets that vaporize into microbubbles for ultrasound detection. The method delivers micrometer‑scale spatial resolution and high contrast‑to‑noise ratios, surpassing traditional ultrasound. Activation is tunable via laser wavelength and pulse settings, allowing...
Hydroxychloroquine Fails to Improve COVID-19 Blood Biomarkers
A recent clinical trial found that hydroxychloroquine does not improve key blood biomarkers in COVID-19 patients. The study measured inflammatory markers, cytokine levels, and viral load among hospitalized individuals with moderate disease severity. No statistically significant changes were observed compared...
Reduced Body Segmentation in Skeleton Shrimp Revealed
Researchers led by Y. Otomo, R. Kimbara and K. Oguchi have documented a pronounced reduction in body segmentation of the skeleton shrimp *Caprella scaura*. By dissecting internal musculature and skeletal structures, the team demonstrated that this morphological simplification improves flexibility and maneuverability in...
Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More
Roche announced that its GLP‑1/GIP candidate CT‑388 achieved a 22.5% average weight loss in a Phase II study and will launch a Phase III trial early this year, pairing the drug with a Zealand Pharma therapy to curb gastrointestinal side effects. Baseline...
Lilly, Seamless Ink Up-to-$1.12B Hearing Loss Collaboration
Eli Lilly has signed a global research and licensing deal with German gene‑editing startup Seamless Therapeutics to develop hearing‑loss treatments using Seamless’s programmable recombinase platform. The agreement grants Lilly exclusive rights to engineered recombinases that can insert large DNA fragments...
Lilly Partners with Recombinase-Based Gene Editing Startup Seamless Therapeutics
Eli Lilly has entered a partnership with Seamless Therapeutics, a startup pioneering recombinase‑based gene editing. The collaboration will combine Lilly’s drug development platform with Seamless’s proprietary recombinase enzymes to create precise, permanent DNA modifications for therapeutic applications. Under the agreement,...
Boehringer Ingelheim Takes Rare Kidney Disease Drug to Phase 3 Despite Puzzling Mid-Stage Data
Boehringer Ingelheim announced that its experimental oral therapy for a rare kidney disorder will advance to a pivotal Phase 3 trial. The decision follows a Phase 2 study that demonstrated modest improvements in glomerular filtration rate but produced puzzling efficacy signals across...
CMS's Medicare Price Negotiations Start Round Three
The Centers for Medicare & Medicaid Services released the third round of Medicare drug price negotiations, naming 15 drugs that will face mandatory discounts starting in 2028. The list, which adds Eli Lilly’s GLP‑1 therapy Trulicity and several physician‑administered products such...
Curcuma Longa Starch for Effective Green Synthesis of Cerium Oxide Nanoparticles
Researchers have introduced a green synthesis route for cerium oxide nanodots using debranched Curcuma longa starch, achieving uniform 2–4 nm particles. The starch acts as both reducing and stabilizing agent, eliminating the need for toxic solvents and high‑temperature steps. In vitro...
HIV Diagnosis Impact on Dutch Labor Market
A new Dutch study finds that an HIV diagnosis significantly harms labor market outcomes. Diagnosed workers experience an average 12% wage reduction and an 8% higher unemployment risk within two years. The research attributes most losses to employer discrimination and...
Seven Italian Biotechs to Know About in 2026
Italy’s biotech sector, though less visible, hosts several companies poised for global impact in 2026. AAVantgarde Bio secured a $141 million Series B to launch dual‑AAV gene therapies for Stargardt disease and Usher syndrome, while Genenta Science rebranded as Saentra Forge to broaden...
Chemotherapy Rewires Gut Bacteria to Curb Metastasis
A study in Nature Communications shows chemotherapy‑induced gut injury reshapes the microbiota, increasing production of the microbial metabolite indole‑3‑propionic acid (IPA). Elevated systemic IPA reaches the bone marrow, reprogramming myelopoiesis to lower immunosuppressive monocytes and boost T‑cell activity. In preclinical...
Evaluating Vyvgart®’s Impact on Myasthenia Gravis in Spain
A recent multi‑criteria decision analysis by Cortés‑Vicente et al. evaluates Vyvgart® (efgartigimod alfa) for generalized myasthenia gravis (gMG) in Spain. The study finds the Fc‑fragment therapy lowers pathogenic antibodies, improves muscle strength, and boosts health‑related quality‑of‑life. Safety compares favorably to...
Hospital Stay and Outcomes in CNS Lymphoma Study
French researchers conducted a retrospective multicenter analysis of primary central nervous system lymphoma patients, linking hospital length of stay to survival outcomes. The study found that longer admissions often reflected more intensive chemotherapy regimens, which were associated with improved survival,...
Uncovering Ochratoxin A’s Role in Liver Cancer
Recent research has identified a stronger causal link between chronic exposure to the mycotoxin Ochratoxin A (OTA) and the development of hepatocellular carcinoma. The study combined long‑term rodent feeding trials with analysis of human liver biopsies, revealing a dose‑dependent increase...
Link Between Oral Health and Dementia in Seniors
A new ten‑year longitudinal study of 5,000 seniors found that individuals with poor oral hygiene were 30% more likely to develop dementia. Researchers detected periodontal bacteria DNA in brain tissue of participants who later exhibited cognitive decline. The analysis controlled...
Recognizing Pediatric Chordoma’s Poorly Differentiated Subtype
Researchers have identified a distinct poorly differentiated subtype of pediatric chordoma, characterized by loss of SMARCB1 (INI1) expression and unique histologic features. Advanced imaging reveals heterogeneous, infiltrative patterns that differ from classic chordoma presentations. Early clinical data suggest that conventional...
Multicondition Profiling Challenges Role of Housekeeping Genes
A new multicondition profiling study demonstrates that traditional housekeeping genes are not uniformly stable across diverse biological states. By analyzing thousands of RNA‑seq datasets, researchers found significant expression fluctuations in genes long used for normalization. The findings call into question...
Science-Led CX: Why Proof Builds Loyalty in Health Retail
Health‑focused retailers are moving beyond flashy trends to a science‑led customer experience, where proof of efficacy replaces hype. Consumers in wellness, skincare and family‑health categories now demand clinical backing, clear ingredient origins and regulatory compliance before they commit. Brands like...
Exploring Metastatic Salivary Gland Carcinoma Insights
Researchers at a tertiary care center have completed comprehensive molecular profiling of metastatic and recurrent salivary gland carcinoma, identifying key gene mutations, copy-number changes, and fusions that correlate with tumor aggressiveness and patient survival. The study also maps the tumor...
Zalcitabine Triggers Ferroptosis in Multiple Myeloma Cells
Researchers have discovered that the antiviral drug zalcitabine can trigger ferroptosis, an iron‑dependent form of cell death, in multiple myeloma cells. Laboratory experiments showed significant lipid‑peroxide accumulation and loss of viability at micromolar concentrations. The effect was amplified when zalcitabine...
Broadening T Cell Control in Atopic Dermatitis
Corvus Pharmaceuticals reported Phase I efficacy for its oral ITK inhibitor soquelitinib in 24 atopic dermatitis patients who had failed prior therapies. The drug targets upstream T‑cell activation, diverging from the cytokine‑blocking strategy of market leaders Dupixent and Rinvoq. Investors...
L-Fucose: A Sugar with Cancer Therapy Potential
Researchers are investigating L‑fucose, a rare monosaccharide, as a novel adjunct in cancer therapy. Pre‑clinical models show that supplementing L‑fucose can modulate tumor glycosylation, enhancing immune recognition and reducing metastatic spread. Early phase trials report improved response rates when L‑fucose...
Hormonal Contraceptives Influence Women’s Jealousy and Competition
New research published in Journal of Evolutionary Psychology shows that hormonal contraceptives significantly alter women's emotional responses, increasing jealousy toward perceived rivals and amplifying competitive drives. The study, which surveyed over 1,200 women across multiple countries, found that synthetic estrogen...